The neuroprotective and neurotransmitter-modulating properties of L-theanine make it uniquely suited to address the cognitive and psychological burdens of chronic illness
ICIs work by blocking the interactions between immune checkpoints such as CTL-associated protein 4 (CTLA-4), programmed cell death-1 (PD-1), and programmed cell death ligand-1 (PD-L1) and their ligands, which releases the inhibitory brakes of T cells and results in the robust activation of immune responses (Fig
Clinical Benefits: Regulates calcium and phosphate metabolism for bone and muscle health Supports immune system modulation and reduces susceptibility to infection Associated with improved mood and reduced risk of seasonal affective symptoms May help reduce systemic inflammation Supports neuromuscular function Effective for patients with malabsorption conditions or persistent oral supplementation failure A blood test can be arranged to confirm deficiency prior to treatment, though this is not always required
Topical immunomodulators such as tacrolimus and pimecrolimus attenuate the production of proinflammatory cytokines by inhibiting T cell activity, thereby enhancing melanocyte migration and pigmentation in vitiligo patients (Ormerod 2005)
In addition, surface transporters of epithelial cells, such as glucose transporter GLUT2 and amino acid transporter SGLT1, can specifically transport nutrients, further enhancing the selectivity of permeability
5 billion CFU guaranteed until expiry
